For general education only. This information does not diagnose a condition or replace medical advice. Your provider will determine which evaluation or treatment is appropriate for you.
Match the discussion to the cause
Shedding, inherited thinning, and scalp conditions are not treated identically. An examination and targeted evaluation may be needed before considering medicines. Supplements do not replace identifying the cause.
Formulations are not interchangeable
Topical minoxidil is an approved option for female pattern hair loss in specific products. Oral minoxidil use for hair loss is off label. Route and formulation affect the risks and instructions, so ask which exact product is being discussed.
Other listed medicines may be considered for specific diagnoses or off label uses. Finasteride and dutasteride have important pregnancy restrictions and are not routine choices for everyone. Ketoconazole addresses certain scalp conditions, not every cause of thinning.
Understand limitations and safety
FDA approval applies to a specific product, formulation, indication, and population. Off label use means an approved medicine is prescribed outside its approved labeling. A compounded preparation is not FDA approved and has not undergone the same premarket review for safety, effectiveness, and quality.
Benefits vary and hair changes take time. Discuss scalp reactions, systemic risks where relevant, other medicines, and whether pregnancy or breastfeeding changes the options. Your provider will determine suitability.
Agree on a review plan
Ask how progress will be documented and when to reassess. Sudden, painful, or patchy loss may warrant specialist evaluation rather than waiting for a medicine to work.
Questions to bring
- What diagnosis is this option intended to treat?
- Is the proposed formulation approved for this use?
- How do pregnancy plans affect the options?
- What timeline and follow up are appropriate?